Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhinomed.
RELATED STOCKHEAD STORIES
News
ASX Small Cap Lunch Wrap: Who’s really feeling bullish today?
Health & Biotech
ASX Health Stocks: ResApp skyrockets 25% after getting buyout offer from US giant Pfizer
Experts
ScoPo’s Powerplays: Green shoots appear among smaller ASX health stocks
News
Closing Bell: International Graphite climbs 97.5% in its first session, all else is dust
Health & Biotech
ASX Health Stocks: AdAlta gets patent in India, RhinoMed starts selling in Canada
Health & Biotech
ASX Health Stocks: Weed stock Cann Group gets licence from TGA for its cannabis facility
News
10 at 10: These ASX stocks are experiencing a Santa rally this morning
Health & Biotech
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health
News
Closing Bell: ASX slips, explorers run hot and a resources play goes parabolic on debut (again)
News
Closing Bell: ASX finishes flat as investors ponder inflation and booster shots
News
ASX Small Cap Lunch Wrap: Who’s opening the door today?
Health & Biotech
Dr Boreham’s Crucible: Testing times for Covid assay developers
Health & Biotech
Australian Clinical Labs flags revenue boost, amid a surge in COVID-19 testing demand
Health & Biotech
ScoPo’s Powerplays: As focus turns to Delta variant, these ASX health stocks are profiting from COVID-19 testing
Health & Biotech
ASX health stocks: Shares in cancer-fighting company Noxopharm edge higher following its full-year results
Health & Biotech
Rhinomed shares gain another 20pc, after 1 million Rhinoswab order from the Victorian government
News
